Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 30/3/2017
SIETES contiene 91734 citas

 
 
 1 a 4 de 4 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, Gissler M, Norgaard M, Nielsen RB, Zoega H, Valdimarsdóttir U. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 2013;309:48-54. [Ref.ID 94687]
2.Tiene citas relacionadas Cita con resumen
Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB, Norgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012;344:20. [Ref.ID 92313]
3.Enlace a cita original Cita con resumen
Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB, Norgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries . BMJ 2012;343:d8012. [Ref.ID 92200]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
Jonasson JM, Ljung R, Talbäck M, Haglund B, Gudbjörnsdòttir S, Steineck G. Insulin glargine use and short-term incidence of malignancies - a population-based follow-up study in Sweden. Diabetologia 2009;52:1745-54. [Ref.ID 86105]
Seleccionar todas
 
 1 a 4 de 4